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Immobilization of γ-Glutamyl Transpeptidase from Equine
Kidney for the Synthesis of kokumi Compounds
Margherita Bruni+,[a] Marina S. Robescu+,[a] Daniela Ubiali,[a] Giorgio Marrubini,[a]
Renzo Vanna,[b] Carlo Morasso,[b] Ilaria Benucci,[c] Giovanna Speranza,[d] and
Teodora Bavaro*[a]
γ-Glutamyl transpeptidase from equine kidney (ekGGT, E.C.
2.3.2.2) is an intrinsic membrane enzyme which transfers the γ-
glutamyl moiety of glutathione to amino acids and peptides,
thus producing γ-glutamyl derivatives. An immobilization study
of ekGGT was carried out with the aim to develop a robust
biocatalyst for the synthesis of γ-glutamyl amino acids which
are known as kokumi compounds. Heterofunctional octyl-
glyoxyl-agarose resulted in a high immobilization yield and
activity recovery (93% and 88%, respectively). Immobilized
ekGGT retained more than 95% activity under reaction
conditions (Tris-HCl, pH 9, 0.05 M) after 6 days, whereas the
residual activity after 6 reaction cycles (18 days) was 85%. The
synthesis of γ-glutamylmethionine catalyzed by octyl-glyoxyl-
agarose-ekGGT afforded the product in 42% yield (101 mg). The
immobilized ekGGT was characterized by Raman spectroscopy.
The immobilization protocol developed for ekGGT could be of
general applicability to membrane proteins.
1. Introduction
The use of enzymes as biocatalysts in food, pharmaceutical and
fine chemical industries has expanded significantly over the last
decades.[1–3] For a successful application of enzymes, these
catalysts must be stable and fully functional under process
conditions, which often differ from the cellular environment
(temperature, presence of organic cosolvents, pH).[4,5] Enzyme
immobilization on solid supports is a widely used technique to
stabilize proteins and improve their performance in synthetic
applications.[6–8] As a consequence of an enhanced stability,
immobilization allows for enzyme reusability over multiple
catalytic cycles. Moreover, once the biocatalyst is bound to the
support, it becomes a heterogenous catalyst, thus facilitating its
separation from the reaction mixture and minimizing the risk of
product contamination. Protein impurities associated with
molecules synthesized by biocatalysis represent an issue in food
and pharmaceutical processes.[5,9] Many immobilization techni-
ques have been developed, including absorption, entrapment,
encapsulation, cross-linking and covalent binding. The optimal
immobilization method has to be determined experimentally
for each enzyme as it strongly depends on the biocatalytic
process as well as on the enzyme itself.[10] Most of immobiliza-
tion protocols reported in literature are applicable to water-
soluble enzymes but to a very less extent to membrane-bound
proteins, which require a quite hydrophobic environment to
preserve their catalytic activity.[11–13]
Integral membrane proteins (IMPs) represent 15–30% of all
coding sequences in the genome of living organisms.[11,12] IMPs
play essential roles in living cells that can be exploited also ex
vivo for biosensors,[14,15] biocatalytic applications[16,17] and energy
production.[18] The immobilization of membrane-bound proteins
and the design of solid supports mimicking natural membranes
are an active field of research. Liposomes,[19] sol-gel materials[20]
and lipid crystalline cubic phases[21,22] are some of the
membrane mimetic-matrixes developed for IMP immobilization.
By contrast, few examples of covalent immobilization have
been reported to date.[17,23,24]
γ-Glutamyl-transpeptidases (GGTs, EC 2.3.2.2) catalyze the
transfer of the γ-glutamyl moiety of glutathione (GSH) and
other γ-glutamyl compounds to either water (hydrolysis) or
natural and modified amino acids and peptides (transpeptida-
tion), thus producing γ-glutamyl derivatives.[25–28] GGTs are
widely distributed in all living organisms from bacteria to
mammals. Bacterial homologues are generally non glycosylated
soluble proteins, which are localized in the periplasmic space or
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extracellular space, while mammalian GGTs are generally
glycosylated IMPs.[29]
GGTs have been exploited as biocatalysts for the synthesis
of various γ-glutamyl compounds with high added value such
as γ-l-glutamyl-l-DOPA, γ-glutamyl-taurine, γ-d-glutamyl-l-tryp-
tophan and γ-l-glutamyl-ethylamide (l-theanine).[30] Moreover,
γ-glutamyl derivatives of methionine and S-substituted alk(en)yl
cysteines (i. e. methylcysteine, S-allylcysteine and S-trans-prope-
nylcysteine) are known as kokumi compounds. Kokumi is a
Japanese term that refers to taste perception defined as having
mouthfulness, thickness and a long-lasting savory sensation.
Although being nearly tasteless in themselves, kokumi com-
pounds are able to elicit strong taste sensations, especially
when associated with protein-rich food, thus acting as true
flavor enhancers.[31,32] Despite their simple chemical structure,
the synthesis of γ-glutamyl derivatives through the classical
peptide chemistry is troublesome due to the need of protection
and deprotection steps.[33] Therefore, an enzymatic approach
does represent an appealing solution for their supply.
In this work, we described the immobilization study of
equine kidney GGT (ekGGT) for the synthesis of kokumi
peptides. A tailor-made immobilization protocol was set up by
considering that ekGGT is a membrane enzyme and that it is
potentially usable as biocatalyst in the food sector. The
heterofunctional support octyl-glyoxyl (OCGLX)-agarose[34] al-
lowed for the immobilization of ekGGT in two steps: first, the
hydrophobic core of the enzyme was absorbed and stabilized
by the hydrophobic octyl chains of the support, thus mimicking
lipids of cellular membranes, then, the covalent attachment of
the enzyme through the aldehyde groups of the carrier
stabilized the protein against potential enzyme leaching. Raman
spectroscopy was used to characterize the molecular properties
of native and immobilized ekGGT. Finally, the immobilized
ekGGT was used for the preparative synthesis of the kokumi
substance γ-glutamylmethionine.
2. Results and Discussion
2.1. Screening of Immobilization Carriers
With the aim to develop a ekGGT-based biocatalyst suitable for
preparative applications, this enzyme was immobilized on
differently activated agarose carriers. Agarose beads, derived
from a neutral gelling heteropolysaccharide, are porous,
mechanically resistant, and highly hydrophilic. These features
make this biopolymer an ideal carrier for enzyme
immobilization.[35]
As a first approach, GLX-agarose (see Table 1 for abbrevia-
tions) was assayed. This carrier has been widely explored for the
covalent immobilization of enzymes.[36–38]
Immobilization relies on the formation of imine bonds
between the aldehyde groups of the carrier and the lysine ɛ-
NH2 groups of the protein. The immobilization of ekGGT on
GLX-agarose (Table 1, entry 1) gave a high yield in terms of
immobilized protein (80%) and a good activity recovery (30%).
Agarose is a versatile carrier since it can be easily
functionalized by exploiting the reactivity of its hydroxyl
groups.
Thus, we decided to explore an array of binding chemistry.
The reactive groups of GA-EDA-agarose (Table 1, entry 2) are
the same as in GLX-agarose. On the same binding chemistry,
however, GA-EDA-agarose is characterized by a spacer that may
impart a higher flexibility to the immobilized enzyme. In
principle, this scenario could assist in minimizing the distortion
of the protein upon immobilization, thus preserving the enzyme
activity.[39] The immobilization yield was 100% but, surprisingly,
Table 1. Covalent immobilization of ekGGT on agarose-based carriers.[a]
Entry Agarose-based-
carrier[b]
Functional group Activity
[U/g]
Immobilization yield
[%]
Activity recovery
[%]
Efficiency
[%]
1 GLX 3.80 80 30 39
2 GA-EDA 0.21 100 3 3
3 GA-APTES 0.09 21 1 2
4 GPTS 0.17 37 1 6
5 CDI 0.01 14 1 7
6 CNBr 3.00 79 41 53
7 OCGLX 13.70 93 88 95
[a] Legend=GLX: glyoxyl-agarose, GA: glutaraldehyde, EDA: ethylenediamine, APTES: (3-aminopropyl)triethoxysilane, GPTS: (3-glycidyloxypropyl)
trimethoxysilane, CDI: N,N’-carbonyldiimidazole, CNBr: cyanogen bromide, OCGLX: octyl-glyoxyl agarose. [b] Loading: 1 mg ekGGT per g of carrier.
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the immobilized enzyme lost almost completely its activity (3%
activity recovery). An even poorer outcome was obtained by
using GA-APTES-agarose (Table 1, entry 3).
When ekGGT was immobilized on an epoxy carrier (GPTS-
agarose), a moderate immobilization yield was achieved (37%),
but no activity was detected for the immobilized biocatalyst. A
slight improvement was obtained when the enzyme was
immobilized on SepabeadsTM EC-EP/S (100% immobilization
yield, 18% activity recovery), an epoxy-functionalized carrier
which is hydrophobic in nature (methacrylic polymeric matrix).
This evidence highlighted that, on the same binding chemistry,
a less hydrophilic carrier might be better tolerated by the
enzyme. In order to enlarge the screening to a different binding
chemistry, carbamate and isocyanate activation of the carrier
was performed by treatment of agarose with N,N’-carbon-
yldiimidazole (CDI) or CNBr, respectively. In the former case, a
scarce immobilization yield and a negligible activity recovery
were obtained (Table 1, entry 5), whereas CNBr-agarose gave
85% immobilization yield and 41% activity recovery (Table 1,
entry 6).
The use of heterofunctional supports, that bear different
types of active groups on the support surface, has been
previously reported for the immobilization of three lipases
(from Candida antarctica B, Thermomyces lanuginosus and
Rhizomucor miehei), and the artificial phospholipase Lecitase
Ultra.[34] Specifically, OC-agarose was converted into OCGLX-
agarose. Cross-linked octyl-agarose beads have some diols
(resulting from the opening of the epoxy moieties during carrier
preparation) which may be easily oxidized to glyoxyl groups
with periodate.[34]
We hypothesized that such a heterofunctional carrier might
enhance the immobilization of ekGGT through a first mild,
hydrophobic interaction involving the hydrophobic portion of
the enzyme and the octyl chains (mimicking the natural
environment of the protein), followed by a covalent interaction
enzyme-carrier deriving from the formation of imine bonds.
This two-step mechanism can thus answer the need to create a
“favourable” microenvironment for ekGGT immobilization that
prevents it from deactivation, also avoiding undesired enzyme
leaching. Hydrophobic adsorption was carried out in phosphate
buffer at pH 7 and, after 3 hours, a 98% immobilization yield
was obtained. Then, once ekGGT was adsorbed in a close
proximity on the carrier surface, it was incubated at pH 10 to
promote the reactivity of lysine ɛ-NH2 groups towards the
aldehyde groups of the carrier (Scheme 1). As a result,
immobilization of ekGGT was almost complete (93%) and a
very high immobilization efficiency was obtained (95%). In
other words, all the enzyme in solution was immobilized and
almost 100% of activity was found in the immobilized
biocatalyst.[10]
2.2. Study of the Immobilization Process of ekGGT on
OCGLX-Agarose
A systematic study was undertaken in order to evaluate the
critical factors that affected the immobilization of ekGGT on
OCGLX-agarose. The goal of this study was to set up a robust
and reproducible method for this immobilization protocol by
using an experimental design approach (DoE). Upon the critical
revision of all the immobilization steps, six factors (storage time
of the carrier X1, buffer volume X2, stirring system X3, NaBH4
addition X4, time of chemical reduction X5, drying time of the
immobilized biocatalyst X6) were selected. One additional
“Dummy” fictitious factor, used to assay the experimental
variance, was included in the list of the process factors, as
shown in the experimental plan reported in Table 2.
Eight experiments were thus planned by following a
Plackett Burman 8-run design (Table 2), and one further
independent validation experiment was carried out to confirm
the results. The model hypothesized for the description of the
immobilization outcome was a linear model without interac-
tions, as from the general Equation (1):
y ðactivity U=gÞ ¼ b0þ b1 � X1þ b2 � X2þ b3 � X3þ
b4 � X4þ b5 � X5þ b6 � X6þ b7 � X7
(1)
Three factors, namely the storage time of the carrier, the
time of chemical reduction with NaBH4, and the drying time of
the immobilized biocatalyst (X1, X5 and X6) resulted to be those
affecting more than the others the immobilization outcome. As
shown in Table 2 and Figure 1, the carrier storage at 4 °C (X1)
was the most important factor. The activity of the immobilized
enzyme was almost completely lost when the immobilization
protocol was performed after 7 days from carrier preparation.
The immobilization has to be carried out, indeed, after a
maximum lag time of one day after the carrier preparation.
The second factor affecting the immobilization outcome
was the time necessary for the chemical reduction with NaBH4:
the longer is the time of contact enzyme-reducing agent, the
lower is the activity of immobilized ekGGT. Unspecific reduction
of amino acid residues of the protein altering the three-
Scheme 1. Immobilization of ekGGT on OCGLX-agarose. Experimental con-
ditions: (a) 35 μmol NaIO4 per g carrier, r.t., 2 h; (b) ekGGT (1 mgg
  1), KH2PO4
(pH 7, 0.025 M), r.t., 3 h; (c) OCGLX-agarose-ekGGT, NaHCO3 (pH 10, 0.05 M),
r.t., 3 h; (d) NaBH4, pH 10, 30 min.
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dimensional structure of ekGGT cannot be ruled out. Finally, the
time necessary to dry out the immobilized enzyme before
activity measurement also emerged as an important parameter.
Agarose is a sharply hydrophilic polymer thus it can capture a
considerable amount of water inside its polymeric matrix. The
presence of water affects the weight of the immobilized
biocatalyst, unless the drying step is standardized. It was found
that 10 minutes for the s.v. filtration of the biocatalyst was
sufficient to have reproducible results. The remaining 3
parameters, namely buffer volume (2 or 4 mL), type of stirring
(mechanical/shaking), NaBH4 addition (solid/solution), did not
affect significantly the immobilization protocol. To confirm the
reliability of the Plackett-Burman model, validation experiments
were performed by keeping constant the significant factors (X1,
X5 and X6) and changing the negligible ones (X2, X3, X4, X7).
As shown in Table S1, the results were in good agreement with
the predicted outcomes of the model.
2.3. Molecular Characterization of OCGLX-Agarose-ekGGT by
Raman Spectroscopy
The OCGLX-agarose-ekGGT was further characterized by Raman
spectroscopy for a deeper insight into the binding of the
enzyme to the carrier in label-free through a direct, non-
destructive approach.
The analysis was performed on the carrier as such, on the
native enzyme, and on the immobilized enzyme by acquiring
the single spectra. As shown in Figure 2A, both the enzyme and
the carrier were characterized by specific Raman signals.[40] In
the enzyme spectrum (Figure 2A), vibrations associated to
phenylalanine (aromatic stretching, 1002 cm  1), peptide bonds
(amide C  N, N  H, 1305 cm  1), aliphatic chains of amino acids
(CH2, 1447 cm
  1) and amino acids backbone (C=O, 1631 cm  1)
have been detected, while in OCGLX-agarose spectrum typical
signals related to mono- and disaccharides (C  O  C, 848, C  C,
891, C  O, 1083 cm  1) and signals that can be associated to the
aliphatic chain (CH2, 1454 cm
  1) are present. In the spectrum of
the immobilized biocatalyst (Figure 2A), Raman signals of both
ekGGT and OCGLX-agarose are consistent with the occurrence
of an enzyme-carrier interaction (as highlighted by the shift of
some Raman signals: 891, 964, 1077 cm  1).
Once the reference spectra of the two standards (i. e. native
enzyme and carrier) were obtained and after the analysis of the
spectrum of the immobilized biocatalyst, a Raman imaging
mapping experiment was performed in order to explore a small
portion (around 1.5-2 μm of agarose microspheres) of the
enzyme/OCGLX-agarose conjugate. As shown in Figure 2B, the
surface of agarose beads is completely surrounded by the
enzyme, thus suggesting a binding between the enzyme and
support.
2.4. Stability of Immobilized and Native ekGGT
The stability of native ekGGT and OCGLX-agarose-ekGGT were
evaluated under reaction conditions (Tris-HCl buffer, pH 9,
0.05 M 4 °C, in absence of substrate). The immobilized ekGGT
was fully stable for 6 days, while the native enzyme retained
70% of its activity under the same incubation time (Figure 3).
Protein leaching assay on immobilized ekGGT was also
performed. After 6 day-incubation under the reaction condi-
tions, no release of the protein from the carrier was detected, as
indicated by the absence of protein in the supernatant (see
Experimental Section for details).
2.5. Immobilized Biocatalyst Recycling
Recycling of immobilized ekGGT was performed by evaluating
over time the residual activity of the enzyme in the synthesis of
Table 2. Plackett-Burman experimental plan.
Exp# X1
[a]
[days]
X2
[b]
[mL]
X3
[c] X4
[d] X5
[e]
[min]
X6
[f]
[min]
X7
[g] Y[h]
[U/g]
1 7 4 Shaking Solid 60 3   1 2.62
2 1 4 Shaking Solution 30 10   1 13.70
3 1 2 Shaking Solution 60 3 +1 9.97
4 7 2 Mechanical Solid 60 10   1 4.40
5 1 4 Mechanical Solid 60 10 +1 14.38
6 7 2 Shaking Solid 30 10 +1 8.35
7 7 4 Mechanical Solution 30 3 +1 5.54
8 1 2 Mechanical Solid 30 3   1 12.74
[a] Storage time of the carrier at 4 °C; [b] Buffer volume; [c] Mixing mode; [d] NaBH4, [e] Reduction time; [f] Drying time; [g] Dummy; [h] Activity.
Figure 1. Results of Plackett-Burman design.
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γ-glutamylmethionine in Tris-HCl buffer (pH 9, 0.05 M).[33] After
each reaction cycle (3 days), the reaction mixture was filtered
under reduced pressure and the immobilized biocatalyst was
re-used for the following reaction runs. As depicted in Figure 4,
the immobilized ekGGT was successfully re-used for 6 cycles
(18 days) and retained about 80% of its activity, thus showing
an optimal recyclability. This result suggests that OCGLX-
agarose-ekGGT could be re-used for additional reactions.
Furthermore, it is worth pointing out that immobilization
applied to ekGGT exerted more than the “usual” advantages
derived from the heterogeneous catalysis (i. e. recyclability, re-
use, protein stabilization, control of the process). In fact, ekGGT
is a paradigmatic example of how immobilization can be also a
viable technique to offset the high costs associated with
production and use of expensive and hardly available enzymes
(ekGGT is not a recombinant protein but it is extracted from
natural sources in a low yield).
2.6. Preparative Synthesis of γ-Glutamylmethionine
In order to demonstrate the feasibility of a true biocatalytic
application with the immobilized ekGGT, OCGLX-agarose-ekGGT
was used to catalyze the synthesis of γ-glutamylmethionine
also at a preparative scale. 5 U of OCGLX-agarose-ekGGT were
added to a L-methionine solution (333 mM) in Tris-HCl buffer
(pH 9, 0.05 M) in the presence of a 10% molar excess GSH. After
72 hours,[33] the reaction product was isolated by preparative
ion exchange chromatography in 42% yield. This result was
consistent with the data obtained by using the non-immobi-
lized enzyme.[33]
Figure 2. A) Representation of Raman spectra. Green bands represent the
enzyme specific signals. Blue bands represent carrier specific bands. The
shifts in bold are those that have been apparently changed after
immobilization. B) Raman imaging of the immobilized biocatalyst. On the
left, the bright field image of the portion of the sample analyzed by Raman
imaging. On the side (top), the Raman map of the immobilized biocatalyst
produced by merging the signals obtained by the two reference samples
(enzyme-green and carrier-blue). On the side (middle, bottom), the Raman
maps reporting the signals of the single components.
Figure 3. Stability of native ekGGT and OCGLX-agarose-ekGGT.
Figure 4. Biocatalyst recycling. Synthesis of γ-glutamylmethionine catalyzed
by OCGLX-agarose-ekGGT.
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3. Conclusions
In this work, we have developed a tailor-made immobilization
for ekGGT, a membrane enzyme which can be used for the
synthesis of γ-glutamyl amino acids having a great interest
for food applications. γ-Glutamylmethionine was used as the
reference kokumi compound to demonstrate the feasibility of
the ekGGT-catalyzed synthetic application and the excellent
recyclability/stability of the biocatalyst. The heterofunctional
carrier OCGLX-agarose[34] conveys hydrophobic alkyl chains
and aldehyde groups which result in a concurrent non-
covalent and covalent immobilization of the protein. On one
hand, enzyme-carrier hydrophobic interactions, mimicking
what occurs in vivo when the enzyme is anchored to the lipid
membrane, are assumed to stabilize the tertiary folded
structure of the protein, on the other hand, the formation of
stable C  N bonds between the enzyme and the carrier
further stabilizes the protein which can be thus used also in
non-conventional environments.
A key issue in developing an immobilized enzyme for
biocatalytic applications also includes a strict control of all the
numerous variables associated with the immobilization proto-
col. In this frame, the Placket-Burmann design has clearly
highlighted which were the critical factors and the corrections
needed in order to set up a robust and reproducible
immobilization procedure.
Experimental Section
γ-Glutamyl transpeptidase from equine kidney (ekGGT), octyl-
Sepharose® CL-4B (octyl-agarose, OC-agarose), L-glutamic acid γ-
(4-nitroanilide) (GpNA), glycylglycine (Gly-Gly), 4-nitroaniline, L-
methionine, glutathione (GSH), Bradford reagent, cyanogen
bromide activated-Sepharose® 4B (CNBr-agarose), glycidol, so-
dium periodate (NaIO4), sodium borohydride (NaBH4), ethyl-
enediamine (EDA), glutaraldehyde (GA), 3-aminopropyl-triethox-
ysilane (APTES), 3-glycidyloxypropyl-trimethoxysilane (GPTS),
triethylamine (Et3N), potassium phosphate, N,N’-carbonyldiimida-
zole (CDI), Dowex 1×8 ion exchange resin pad (200–400 mesh),
ninhydrin reagent were purchased from Sigma Aldrich (Milano,
Italy). Analytical thin layer chromatography (TLC) was performed
on silica gel F254 precoated aluminium sheets (0.2 mm layer,
Merck, Darmstadt, Germany). SepharoseTM CL-6B (agarose) was
from Amersham Biosciences (Uppsala, Sweden). SepabeadsTM EC-
EP/S was a gift of Resindion S.r.l (Binasco, Italy). Sodium
bicarbonate was from Carlo Erba (Cornaredo, Italy). Spectropho-
tometric assays were performed using a Shimadzu UV-1601 UV-
Visible spectrophotometer equipped with magnetic stirring.
Raman and UV-Vis spectroscopy was performed with a Aramis
Horiba Jobin-Yvon micro-Raman spectrometer equipped with
solid state lasers operating at 633 nm and 785 nm and with a
DuoScan mapping mode configuration.
ekGGT Activity Assay
The standard activity assay (2 mL) was performed at room temper-
ature in Tris-HCl buffer (pH 8.5, 0.1 M) containing GpNA (0.001 M),
Gly-Gly (0.1 M) and an appropriate amount of enzyme (free ekGGT:
1 μg; immobilized ekGGT: 5–15 mg, under magnetic stirring). The
reaction was monitored spectrophotometrically by measuring the
formation of 4-nitroaniline at 410 nm in kinetic mode.[41] The
amount of 4-nitroaniline produced by the enzyme was quantified
by using a calibration curve and a extinction coefficient of 8300 M  1
cm  1. One unit of ekGGT was defined as the amount of enzyme
that produces 1 μmole of 4-nitroaniline per minute from GpNA in
the presence of the acceptor Gly-Gly. The protein content in the
solid crude extract of ekGGT was 50% of its weight based on
Bradford assay;[42] all the activity data reported in this paper are
referred to this percentage.
Preparation of Agarose based Carriers
Glyoxyl-agarose (GLX-agarose) was prepared as reported in
literature.[43] Briefly, SepharoseTM CL-6B (agarose, 5 g) was
suspended in dH2O (1.4 mL) and NaOH (1.7 M, 2.4 mL) containing
NaBH4 (28.4 mgmL
  1). Subsequently, glycidol (1.7 mL) was added
dropwise keeping the vessel at 4 °C in an ice bath. The reaction
was kept under gently stirring overnight at 25 °C. After the
incubation period, the suspension was filtered and the carrier
was washed abundantly with dH2O. Oxidation was initiated by
adding NaIO4 (0.1 M, 34 mL). The reaction was carried out for
2 hours at room temperature, then the carrier was filtered under
reduced pressure and washed abundantly with dH2O and stored
at 4 °C.
GA-EDA-agarose was prepared as described in literature.[36] GLX-
agarose (2 g) was aminated using EDA (pH 10, 2 M, 11.43 mL) for
2 hours and subsequently reduced for 2 hours with NaBH4
(11.4 mg). The EDA-activated agarose was then suspended in
KH2PO4 buffer (pH 7, 0.2 M, 2.3 mL) and a solution of GA (25% (v/v)
in dH2O, 3.4 mL) was added. The mixture was kept under
mechanical stirring for 16 hours at room temperature in the
darkness. The activated carrier was washed abundantly with dH2O
and stored at 4 °C.
GA-APTES-agarose was prepared by modifying a protocol described
in literature.[44] Briefly, SepharoseTM CL-6B (agarose, 3 g) was
suspended in NaOH (0.5 M, 50 mL) for 2 hours. The carrier was
filtered, washed with dH2O and activated with APTS (10% (v/v) in
dH2O, 60 mL) for 24 hours. Then, the carrier was washed and
suspended in KH2PO4 buffer (pH 7, 0.2 M, 10 mL) and GA (25% v/v
in dH2O, 6 mL). The mixture was kept under stirring for 16 hours at
room temperature in the darkness.
GPTS-agarose was prepared as described in literature.[45] Briefly,
dry agarose (3 g) was suspended in dry toluene (60 mL).
Subsequently, GPTS (3 mL) and Et3N (0.45 mL) were added and
the reaction was kept for 24 hours at room temperature under
stirring. The resulting carrier was filtered, washed and dried at
50 °C for 3 hours.
CDI-agarose was prepared by modifying the protocol described in
literature.[46,47] SepharoseTM CL-6B (agarose, 3 g) was suspended in
dry acetone (50 mL) and CDI (5 g) was added. The mixture was kept
under stirring overnight at room temperature. The resulting carrier
was filtered, washed and dried at 50 °C for 3 hours.
Commercial cyanogen bromide-activated-Sepharose® 4B (CNBr-
agarose) (1 g) was hydrated in HCl (0.001 M, 200 mL) for 30
minutes. Then it was washed using NaHCO3 buffer (pH 8, 0.1 M)
and used for the immobilization procedure.
OCGLX-agarose was prepared by octyl-Sepharose® CL-4B (OC-
agarose) oxidation as reported in literature.[34] The glyceryl groups
of OC-agarose (1 g) were oxidized using NaIO4 (35 μmol) for 2 hours
at room temperature under stirring. The oxidation degree of the
carrier was monitored spectrophotometrically by the periodate
assay of the supernatant.[43] Following this procedure, the carrier
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was functionalized with 25–30 μmol aldehyde groups per gram of
carrier.
ekGGT Immobilization
For all the immobilization procedures, an enzyme loading of 1 mg
was used per gram of carrier. A 10 :1 ratio volume of immobilization
reaction/volume of the carrier was used. The protein content in the
solid crude extract of ekGGT was 50% of its weight based on
Bradford assay.[42] During immobilization, the supernatant was
monitored by measuring the amount of protein in solution
(Bradford assay[42]), and the residual activity of the supernatant
(20 μL) was checked by the standard activity assay described
before.
Immobilization of ekGGT on GLX-agarose was performed following
the standard protocol.[43] Briefly, GLX-agarose was washed abun-
dantly with NaHCO3 buffer (pH 10, 0.05 M) and then filtered under
reduced pressure until dryness. The solid crude extract of ekGGT
(400 μg, 200 μg of protein) were solubilized into NaHCO3 buffer
(2.52 mL). Then, the carrier (200 mg) was added and the suspension
was allowed to stir for 4 hours at room temperature. Finally, NaBH4
(2.5 mg) was added to the mixture and incubated for 30 minutes
for imino bonds reduction. The immobilized enzyme was then
filtered, washed with Tris-HCl buffer (pH 8.5, 0.1 M) and stored at
4 °C.
The immobilization of ekGGT on GA-EDA-agarose and GA-APTES-
agarose was carried out in NaHCO3 buffer (pH 10, 0.05 M), while the
immobilization on GPTS-agarose and CDI-agarose was performed in
KH2PO4 buffer (pH 8, 0.05 M). The solid crude extract of ekGGT
(500 μg, 250 μg of protein) was solubilized in the suitable buffer
(3.15 mL) and added to the activated carrier (250 mg); the
suspension was allowed to stir at room temperature. After 24 hours,
the carrier was filtered under reduced pressure, washed with Tris-
HCl buffer (pH 8.5, 0.1 M) and stored at 4 °C.
The immobilization of ekGGT on CNBr-agarose was performed
following a standard procedure.[36] ekGGT solid crude extract
(540 μg, 270 μg of protein) was dissolved in NaHCO3 buffer (pH 8,
0.1 M, 3.5 mL). Subsequently, the hydrated carrier (270 mg),
prepared as previously described, was added. After 3 hours, the
immobilized biocatalyst was filtered and suspended in Tris-HCl
buffer (pH 8, 0.1 M, 3.5 mL) for 2 hours. Then, the immobilized
biocatalyst was washed with Tris-HCl buffer (pH 8.5, 0.1 M) and
stored at 4 °C.
The immobilization protocol on OCGLX-agarose was carried out in
two steps: first, the protein was adsorbed to the carrier, then the
reaction between the carrier aldehydes and the enzyme amino
groups took place.[34] OCGLX-agarose was washed with KH2PO4
buffer (pH 7, 0.025 M). ekGGT solid crude extract (500 μg, 250 μg of
protein) was solubilized in the same buffer (3.15 mL) in the
presence of the carrier (250 mg).[48] After 3 hours, all the protein in
solution was absorbed onto the carrier; the biocatalyst was filtered
and suspended in NaHCO3 buffer (pH 10, 0.05 M, 3.15 mL). Immobi-
lization was carried on for further 3 hours and then NaBH4 (3 mg)
was added. After stirring for 30 minutes, the biocatalyst was
washed with Tris-HCl buffer (pH 8.5, 0.1 M) and stored at 4 °C. For
the preparative synthesis of γ-glutamylmethionine the protein
loading was scaled-up to 2 mgg  1.
Immobilization on SepabeadsTM EC-EP/S was performed as
reported in literature.[49,50] Commercial SepabeadsTM EC-EP/S was
hydrated with dH2O for 1 hour under mechanical stirring. Then,
the carrier was washed with KH2PO4 buffer (pH 8, 1 M). ekGGT
solid crude extract (500 μg, 250 μg of protein) was solubilized in
the same buffer (3.15 mL) and the carrier (250 mg) was added to
the solution. After 24 hours, the carrier was filtered and
resuspended in KH2PO4 buffer (pH 8, 1 M, 3.15 mL) containing
glycine (3 M) for the quenching step. After 21 hours, the
immobilized biocatalyst was washed with Tris-HCl buffer (pH 8.5,
0.1 M) and stored at 4 °C.
Plackett-Burman Design
The first experiments of immobilization were performed using
freshly prepared OCGLX-agarose (one day before starting the
experiments). On the day one, 4 experiments were carried out
(reactions 2, 3, 5 and 8, Table 2). Specifically, ekGGT (1.6 mg) was
dissolved in KH2PO4 buffer (pH 7, 0.025 M, 0.8 mL); meanwhile the
carrier was conditioned with the same buffer and 200 mg of
OCGLX-agarose were used for each immobilization trial. Phosphate
buffer (pH 7, 0.025 M) was added in a vessel (4 mL or 2 mL) for
reactions 5 and 8, respectively, followed by the ekGGT solution
(0.2 mL). Both the reactions were kept under mechanical stirring.
The same procedure was carried out for reactions 2 and 3 (4 mL or
2 mL, respectively) but in this case, the reactions were stirred by a
rotary shaker. After 3 hours, solid NaBH4 (1 mgmL
  1) was added to
reactions 5 and 8. After 30 min, reaction 8 was filtered and washed
with Tris-HCl buffer (pH 8.5, 0.1 M) and dried for 3 min. The same
procedure was performed for reaction 5, but prolonging to 60 min
the chemical reduction step. In this case, the immobilized ekGGT
was filtered and dried s.v. for 10 min. For reactions 2 and 3, NaBH4
was dissolved in water (2 mgmL  1) prior to addition to the reaction
mixture (4 mL and 2 mL, respectively). After 30 min, reaction 2 was
filtered, washed with Tris-HCl buffer (pH 8.5, 0.1 M) and dried for
10 min, whereas the reduction step for reaction 3 was 60 min and
the drying time of the biocatalyst after filtration s.v. was 3 min. The
standard activity assay was performed twice on each of the 4
immobilized biocatalysts.
The immobilization was also performed using OCGLX-agarose
stored at 4 °C for one week. On the seventh day, 4 experiments
were carried out (reactions 1, 4, 6 and 7, Table 2). Specifically,
ekGGT (1.6 mg) was dissolved in KH2PO4 buffer (pH 7, 0.025 M,
0.8 mL); meanwhile the carrier was conditioned with the same
buffer and 200 mg of OCGLX-agarose were used for each immobi-
lization trial. Phosphate buffer (pH 7, 0.025 M) was added in a vessel
(2 mL or 4 mL) for reactions 4, 6 and 1, 7, respectively, followed by
the ekGGT solution (0.2 mL). Reactions 4 and 7 were kept under
mechanical stirring while reactions 6 and 1 were stirred by a rotary
shaker. After 3 hours, to reactions 4 and 7, an appropriate volume
of an aqueous stock solution of NaBH4 (2 mgmL
  1) was added in
order to reach a final concentration of 1 mgmL  1. After 30 min,
reaction 7 was filtered, washed with Tris-HCl buffer (pH 8.5, 0.1 M)
and dried for 3 min, whereas the reduction step for reaction 4 was
60 min and the drying time of the biocatalyst after filtration s.v. was
10 min. Reactions 1 and 6 were incubated with solid NaBH4
(1 mgmL  1) for 60 min and 30 min, respectively. After the chemical
reduction step, reactions 1 and 6 were washed and dried s.v. for 3
and 10 min, respectively. The standard activity assay was performed
twice on each of the 4 immobilized biocatalysts.
Raman Spectroscopy
The enzyme (ekGGT), the carrier (OCGLX-agarose), and the immobi-
lized biocatalyst (OCGLX-agarose-ekGGT) were analyzed by a
Raman microspectroscope equipped with a diode-pumped solid-
state laser operating at 532 nm and a Peltier-cooled CCD detector.
Each sample was deposited on a calcium fluoride slide and allowed
to air dry. All the measurements were performed with 100×
objective (NA 0.75, Olympus, Tokyo, Japan), 1800 grooves/mm
diffraction grating, 400 μm entrance slit, and confocal mode
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(600 μm pinhole) in the spectral ranges 500–1800 cm  1 and 2600–
3200 cm  1. Accumulation times were 2×10 s per spectrum. The
Raman shift was calibrated automatically using LabSpec 6 software
(Horiba) using zero order line and Si line of a Si reference sample. In
order to capture the spectra randomly, maps of about 150 μm2
(with lateral steps of 20–30 μm) were acquired in the centre and at
the borders of the samples.
ekGGT Stability
The enzyme stability was evaluated in Tris-HCl buffer (0.05 M,
pH 9.0) during a 6-day period at 4 °C. The samples were periodically
withdrawn and their activities were measured by the standard
activity assay described before. After 6 day-incubation, no protein
release from the carrier was detected, as indicated by the absence
of protein in the supernatant (Bradford assay[42]).
ekGGT Recycling
The recycle of immobilized ekGGT was performed according to
the procedure described in literature.[33] One glass sample holder
with a stirring bar was filled with L-methionine (149 mg,
1.0 mmol) and GSH (338 mg, 1.1 mmol). L-Methionine and GSH
were solubilized in Tris-HCl buffer (pH 9, 0.05 M, 1 mL) under
stirring. The pH was adjusted to 9 with NaOH (2 M) and stirring
was maintained until the solution was completely clear. After-
wards, 2 mL of the same buffer were added to the reaction
mixture. A specific amount of immobilized biocatalyst (5 U) was
added. The mixture was kept at 4 °C under stirring for 3 days. The
reaction mixture was filtered on a Büchner funnel s.v. and the
immobilized biocatalyst was re-used for the second reaction run.
The residual activity of immobilized ekGGT was measured by the
standard activity assay described before.
Preparative Synthesis of γ-Glutamylmethionine
L-Methionine (149 mg, 1.0 mmol) and GSH (338 mg, 1.1 mmol)
were suspended in Tris-HCl buffer (pH 8.5, 0.05 M, ca 1 mL). The
pH was adjusted to 9.0 with NaOH (2 M) until a clear solution
was obtained, then the solution was diluted to a final volume of
3 mL with the same buffer. The reaction was initiated by addition
of the immobilized enzyme (5 U). After 72 hours at 4 °C, the
reaction was filtered to remove the immobilized enzyme and the
pH of the reaction mixture was adjusted to 9.5–10 with NaOH
(2 M); the solution was charged onto a Dowex 1×8 ion exchange
resin pad (200–400 mesh) in the acetate form. The resin pad
(14 cm) was conditioned with glacial acetic acid (6 volumes) and
washed abundantly with water (20 volumes; until the pH was
almost neutral). The elution was performed with CH3COOH
(0.1 M, 0.25 M, 0.5 M and 2 M; three column volumes each).
Unreacted L-methionine was eluted in the void volume and in
the first volume of 0.1 M CH3COOH, γ-glutamylmethionine was
eluted between 0.25 M and 0.5 M, while unreacted GSH was
eluted with 2 M CH3COOH. Fractions containing the desired
product were checked by TLC, combined and dried under
vacuum (yield: 42%, 101 mg). The mobile phase used for TLC
analysis was n-butanol/ dH2O/ acetic acid (4 : 1 : 1). TLC were
eluted twice and analyte detection was performed by using 1%
v/v ninhydrin in ethanol. 1H-NMR and ESI-MS analyses were in
agreement with literature data.[33]
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